145 related articles for article (PubMed ID: 6837902)
1. Labetalol in tetanus. The treatment of sympathetic nervous system overactivity.
Wesley AG; Hariparsad D; Pather M; Rocke DA
Anaesthesia; 1983 Mar; 38(3):243-9. PubMed ID: 6837902
[TBL] [Abstract][Full Text] [Related]
2. Morphine in tetanus--the management of sympathetic nervous system overactivity.
Rocke DA; Wesley AG; Pather M; Calver AD; Hariparsad D
S Afr Med J; 1986 Nov; 70(11):666-8. PubMed ID: 3787380
[TBL] [Abstract][Full Text] [Related]
3. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
Prichard BN
Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891
[TBL] [Abstract][Full Text] [Related]
4. Oral labetalol in the management of the sympathetic overactivity of severe tetanus.
Hanna W; Grell GA
South Med J; 1980 May; 73(5):653-4. PubMed ID: 6103586
[No Abstract] [Full Text] [Related]
5. Hemodynamic effects of labetalol, an alpha and beta adrenergic blocking agent, in hypertensive subjects.
Mehta J; Cohn JN
Circulation; 1977 Feb; 55(2):370-5. PubMed ID: 12880
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic and coronary effects of intravenous labetalol in coronary artery disease.
Gagnon RM; Morissette M; Présant S; Savard D; Lemire J
Am J Cardiol; 1982 Apr; 49(5):1267-9. PubMed ID: 7064851
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular effects of labetalol during halothane anaesthesia.
Scott DB; Buckley FP; Drummond GB; Littlewoods DG; Macrae WR
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):817-21. PubMed ID: 990159
[TBL] [Abstract][Full Text] [Related]
8. Effects of combined alpha- and beta-blockade by labetalol in patients with coronary artery disease.
Condorelli M; Brevetti G; Chiariello M; Miceli D; Lavecchia G; Paudice G; Verrienti S
Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):101S-110S. PubMed ID: 7093092
[TBL] [Abstract][Full Text] [Related]
9. Hyperadrenergic syndrome in severe tetanus: extreme rise in catecholamines responsive to labetalol.
Domenighetti GM; Savary G; Stricker H
Br Med J (Clin Res Ed); 1984 May; 288(6429):1483-4. PubMed ID: 6426611
[TBL] [Abstract][Full Text] [Related]
10. The acute and chronic hypotensive effect of labetalol and the relationship with pretreatment plasma noradrenaline levels.
Agabiti-Rosei E; Alicandri CL; Beschi M; Castellano M; Fariello R; Montini E; Muiesan ML; Romanelli G; Muiesan G
Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):87S-92S. PubMed ID: 7093104
[TBL] [Abstract][Full Text] [Related]
11. Haemodynamic effects of combined alpha- and beta-adrenoreceptor blockade after intravenous labetalol in hypertensive patients at rest and during exercise.
Koch G
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):725-8. PubMed ID: 10950
[TBL] [Abstract][Full Text] [Related]
12. Comparison of effects on cerebral blood flow of rapid reduction in systemic arterial pressure by diazoxide and labetalol in hypertensive patients: preliminary findings.
Pearson RM; Griffith DN; Woollard M; James IM; Havard CW
Br J Clin Pharmacol; 1979; 8(Suppl 2):195S-198S. PubMed ID: 526401
[TBL] [Abstract][Full Text] [Related]
13. Systemic, pulmonary, and coronary hemodynamic effects of labetalol in hypertensive subjects.
Mehta J; Feldman RL; Marx JD; Kelly GA
Am J Med; 1983 Oct; 75(4A):32-9. PubMed ID: 6638039
[TBL] [Abstract][Full Text] [Related]
14. Circulatory responses to thiopentone and tracheal intubation in patients with coronary artery disease. Effects of pretreatment with labetalol.
Fischler M; Dubois C; Brodaty D; Schlumberger S; Melchior JC; Guilmet D; Vourc'h G
Br J Anaesth; 1985 May; 57(5):493-6. PubMed ID: 3888239
[TBL] [Abstract][Full Text] [Related]
15. Labetalol for the control of elevated blood pressure following coronary artery bypass grafting.
Sladen RN; Klamerus KJ; Swafford MW; Prough DS; Mann HJ; Leslie JB; Goldberg JS; Levitsky S; Molina JE; Mills SA
J Cardiothorac Anesth; 1990 Apr; 4(2):210-21. PubMed ID: 2131869
[TBL] [Abstract][Full Text] [Related]
16. Intravenous labetalol in severe hypertension. Effects on blood pressure, plasma renin activity and catecholamines.
Lechi A; Picotti GB; Covi G; Pomari S; Pedrolli E; Cesura AM; Danti G; Mattioli M
Arzneimittelforschung; 1981; 31(3):524-6. PubMed ID: 7013770
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular disturbances in severe tetanus due to overactivity of the sympathetic nervous system.
Corbett JL; Kerr JH; Prys-Roberts C; Smith AC; Spalding JM
Anaesthesia; 1969 Apr; 24(2):198-212. PubMed ID: 5774711
[No Abstract] [Full Text] [Related]
18. Haemodynamic effects of long-term oral labetalol.
Edwards RC; Raftery EB
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):733-6. PubMed ID: 791328
[TBL] [Abstract][Full Text] [Related]
19. Treatment of hypertension with labetalol in neurosurgical practice. Influence of labetalol on cerebral perfusion pressure in dogs without and with intracranial mass lesions.
Puchstein C; van Aken H; Hidding J; Anger C; Lawin P
Acta Neurochir (Wien); 1983; 67(3-4):283-90. PubMed ID: 6846084
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular dynamics after acute and long-term alpha- and beta-adrenoceptor blockade at rest, supine and standing, and during exercise.
Koch G
Br J Clin Pharmacol; 1979; 8(Suppl 2):101S-105S. PubMed ID: 43162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
